Sergio Waxman, MD
Interventional Cardiology · Burlington, MANPI 1720003494
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $108,657 of the $147,711 with a category attached, or 73.6%. 39 manufacturers reported payments, led by Boston Scientific at 39.0% of the total. Reporting peaked in 2019 at $40,459 and has fallen 63.0% since, to $14,977 in 2025. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $328.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$58K
- Edwards Lifesciences$17K
- Medtronic$15K
- Biocardia, Inc.$13K
- Procyrion, Inc.$10K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$8K
- plus $28K from 33 others
Across 55 payments — averaging $2089.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$62K
- Cardiovascular Systems Inc.$22K
- Abbott$16K
- Surmodics, Inc.$10K
- Medtronic$5K
- Boston Scientific$1K
What the payments were for
- Consulting fees$108,65774%
- Speaking & faculty fees$9,5006%
- Travel & lodging$17,34412%
- Food & beverage$12,2108%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 110 | $57,673 |
| Edwards Lifesciences | 62 | $16,708 |
| Medtronic(2 entities) | 71 | $14,687 |
| Biocardia, Inc. | 2 | $12,800 |
| Procyrion, Inc. | 3 | $9,713 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $8,189 |
| Surmodics, Inc. | 14 | $7,150 |
| Abbott | 39 | $6,187 |
| W. L. Gore & Associates, Inc. | 5 | $5,360 |
| ZOLL Circulation Inc | 13 | $1,702 |
| Siemens Medical Solutions USA, Inc. | 13 | $1,418 |
| Heartflow, Inc. | 9 | $1,100 |
| Philips North America LLC | 12 | $1,062 |
| Shockwave Medical, Inc | 6 | $675 |
| Cardiovascular Systems Inc. | 7 | $565 |
| Bard Peripheral Vascular, Inc. | 6 | $345 |
| Abiomed | 3 | $307 |
| Cvrx, Inc. | 2 | $277 |
| Endologix LLC | 3 | $208 |
| Novartis | 13 | $199 |
| Cardiva Medical, Inc. | 8 | $177 |
| Stryker | 3 | $176 |
| Irhythm Technologies, Inc. | 2 | $159 |
| Cordis US CORP. | 1 | $135 |
| Amgen | 8 | $124 |
| Inari Medical, Inc. | 3 | $104 |
| Pfizer | 6 | $98 |
| EKOS Corporation | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 4 | $52 |
| Baxter Healthcare | 1 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $49 |
| Limflow Inc. | 1 | $40 |
| Haemonetics Corporation | 1 | $36 |
| Johnson & Johnson | 2 | $31 |
| Recor Medical Inc | 1 | $25 |
| Acist Medical Systems, Inc. | 1 | $21 |
| Cagent Vascular Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLINICAL TRIAL PRODUCT$50,021
- AORTIX SYSTEM$9,713
- RESOLUTE ONYX$9,682
- LifeVest$8,000
- SurVeil$7,000
- GORE CARDIOFORM Septal Occluder$5,360
- GENERAL - STRUCTURAL HEART$3,475
- CoreValve Evolut$2,357
- Absorb GT1$2,000
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,990
- TherOx DS2 Console$1,285
- Catheter$1,285
- Downstream Cartridge$1,285
- Artis pheno$1,209
- Tendyne Mitral Valve System$1,065
- TRICLIP$1,045
- FFRct$911
- Azurion 7 M20$634
- COREVALVE EVOLUT R$571
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$516
How this compares
$147,711 in reported general payments places this provider in the 90th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Burlington
- Thomas PiemonteBurlington$330K
- Sareena GeorgeBurlington$58K
- Frederic ResnicBurlington$29K
- Michael LevyBurlington$5K
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Suzanne BaronBoston$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.